Charles River Laboratories International, Inc. CRL

292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(2.48%) (4.35%) (6.01%) (7.69%)
ROA
(1.15%) (1.97%) (2.41%) (3.16%)
ROIC
1.63% 0.31% 0.81% 1.07%
Return on Tangible Assets
(4.45%) (7.28%) (9.69%) (12.62%)
Average Days of Receivables
66.63 64.44 63.47 64.96
Free Cash Flow per Share
11.05 10.46 7.99 7.72
Free Cash Flow
543.67 518.49 391.29 370.61
Capital Expenditures
(205.82) (219.15) (215.74) (211.54)
Piotroski F-Score
2.00 4.00 3.00 4.00
Other line items
Cash ROIC
12.92% 13.36% 10.46% 10.29%
Accounts Receivable Turnover
5.41 5.62 5.53 5.41
Accounts Payable Turnover
17.84 18.62 19.25 18.78
Inventory Turnover
8.54 9.32 8.39 8.60
Average Days of Payables
22.71 20.17 17.93 19.11
Days of Inventory on Hand
40.51 40.55 48.15 46.94
Tax Rate
2.59 0.43 0.11 0.29
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
18.46% 18.51% 18.00% 19.06%
Share Based Compensation of Revenue
1.76% 1.77% 1.99% 2.08%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
(8.41) (5.11) (3.29) (2.44)
Depreciation/Fixed assets
0.40 0.34 0.34 0.31
Capex/Depreciation
(0.32) (0.39) (0.42) (0.46)
Revenue per Share
81.76 81.01 82.27 83.28
Operating CF per Share
15.23 14.88 12.40 12.12
Capex per Share
(4.18) (4.42) (4.41) (4.41)
Capex to Sales
0.05 0.05 0.05 0.05
Net Profit Margin
(2.21%) (3.59%) (4.59%) (5.96%)

Fold the line items

Columns are period end dates